Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Anus Neoplasms, Bile Duct Neoplasms, Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasms, Wilms Tumor, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral

NCT02312804 2015-02-16

Ph Ib/BGJ398/Cervix and Other Solid Tumors

Phase 1 Withdrawn

Gynecologic

Uterine Cervical Neoplasms, Neoplasms

NCT01235897 2014-04-17

MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies

Phase 1 Completed

17 enrolled 7 charts

Tumor-Agnostic

Neoplasms

NCT01031212 2013-05-13

ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors

Phase 1 Withdrawn

Tumor-Agnostic

Neoplasms

NCT00581971 2013-04-25

RAD0201

Phase 1/2 Completed

30 enrolled 8 charts

Head & Neck

Head and Neck Neoplasms, Neoplasms

NCT01700010 2013-01-17

Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer

Phase 2 Withdrawn

Genitourinary

Urinary Bladder Neoplasms, Neoplasms

NCT00750386 2011-05-23

Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas

Phase 1/2 Completed

50 enrolled

Gynecologic

Neoplasms, Ovarian Neoplasms

NCT00323583 2007-05-08

Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer

Phase 2 Unknown

80 enrolled

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

Clinical Trials

I-SPY

HYPERBOLIC

GRACIE

Pembro+Chemo in Brain Mets

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI

Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer

AtTEnd

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer

ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK

GALAXY-1

Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer

ETNA

Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer

BiOnHER

Antineoplastic Drugs in Elderly Patients

Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory Cancer

Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts

COPELIA

Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary

Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients

Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194

Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian

Phase II Study for Solid Metastatic Tumors

Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer

Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer

Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary

Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)

A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

Combination Paclitaxel, Carboplatin and Temozolomide

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer